Amalgamated Bank Purchases 1,592 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Amalgamated Bank increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the 4th quarter, HoldingsChannel reports. The firm owned 78,171 shares of the medical equipment provider’s stock after acquiring an additional 1,592 shares during the quarter. Amalgamated Bank’s holdings in Intuitive Surgical were worth $40,802,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical during the fourth quarter worth about $28,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the third quarter worth about $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $101,332.00. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,720,023. The trade was a 2.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,240 shares of company stock worth $3,529,040 in the last 90 days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 0.1 %

Shares of NASDAQ ISRG opened at $591.01 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock’s 50 day moving average price is $566.43 and its 200-day moving average price is $526.49. The company has a market capitalization of $210.51 billion, a PE ratio of 92.20, a PEG ratio of 5.85 and a beta of 1.39.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Raymond James increased their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Truist Financial lifted their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Finally, Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.